Fundz

Climb Bio Appoints Susan Altschuller as Chief Financial Officer

PUBLIC · CLYMOct 01, 2025

Position

Chief Financial Officer

Company

Climb Bio, Inc.

Susan Altschuller
Wellesley HillsBiotechnologyHealthcareHealth Careresearch

Description

Climb Bio, Inc. has strengthened its leadership team with the addition of Susan Altschuller, Ph.D., MBA, as Chief Financial Officer. Susan brings over two decades of strategic and financial leadership experience to the company.

Quick answer

Climb Bio Appoints Susan Altschuller as Chief Financial Officer (October 1, 2025). Climb Bio, Inc. is based in Wellesley Hills, Massachusetts, United States.

Who is the new Chief Financial Officer at Climb Bio, Inc?
Climb Bio, Inc. named Susan Altschuller Chief Financial Officer, announced October 1, 2025.
What did Climb Bio, Inc. announce on October 1, 2025?
Climb Bio, Inc. has strengthened its leadership team with the addition of Susan Altschuller, Ph.D., MBA, as Chief Financial Officer. Susan brings over two decades of strategic and financial leadership experience to the company.
What does Climb Bio, Inc. do?
Eliem Therapeutics is developing life-changing therapies for nervous system disorders.
Where is Climb Bio, Inc. based?
Climb Bio, Inc. is based in Wellesley Hills, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Sera Prognostics (October 1, 2025), Symeres (October 1, 2025), Tessellate Bio (October 1, 2025) and Inventiva (October 1, 2025) also announced leadership changes within 45 days of Climb Bio, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Climb Bio, Inc., and when

A new leader at Climb Bio, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Climb Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Climb Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Climb Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Climb Bio, Inc.

Location

Wellesley Hills, Massachusetts, United States

About

Eliem Therapeutics is developing life-changing therapies for nervous system disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Climb Bio, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Emily
Senior decision-maker at this company
••••••••@••••••••

See Emily's verified email →

Ashley
Senior decision-maker at this company
••••••••@••••••••

See Ashley's verified email →

Susan
Senior decision-maker at this company
••••••••@••••••••

See Susan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Climb Bio, Inc.'s next move

Learn about Strategic plan

Climb Bio, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.